1. A Phase II Study of Amrubicin as a Third‐Line or Fourth‐Line Chemotherapy for Patients With Non‐Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901. (26th February 2013) Authors: Harada, Toshiyuki; Oizumi, Satoshi; Ito, Kenichiro; Takamura, Kei; Kikuchi, Eiki; Kuda, Tomoya; Sugawara, Shunichi; Suzuki, Aya; Maemondo, Makoto; Fujita, Yuka; Kinoshita, Ichiro; Inoue, Akira; Hommura, Fumihiro; Katsuura, Yutaka; Dosaka‐Akita, Hirotoshi; Isobe, Hiroshi; Nishimura, Masaharu Journal: Oncologist Issue: Volume 18:Number 4(2013) Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase II study of bevacizumab with carboplatin-pemetrexed in non-squamous non-small cell lung carcinoma patients with malignant pleural effusions: North East Japan Study Group Trial NEJ013A. (September 2016) Authors: Usui, Kazuhiro; Sugawara, Shunichi; Nishitsuji, Masaru; Fujita, Yuka; Inoue, Akira; Mouri, Atsuto; Watanabe, Hiroshi; Sakai, Hiroshi; Kinoshita, Ichiro; Ohhara, Yoshihito; Maemondo, Makoto; Kagamu, Hiroshi; Hagiwara, Koichi; Kobayashi, Kunihiko Journal: Lung cancer Issue: Volume 99(2016) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial. Issue 10308 (9th October 2021) Authors: Felip, Enriqueta; Altorki, Nasser; Zhou, Caicun; Csőszi, Tibor; Vynnychenko, Ihor; Goloborodko, Oleksandr; Luft, Alexander; Akopov, Andrey; Martinez-Marti, Alex; Kenmotsu, Hirotsugu; Chen, Yuh-Min; Chella, Antonio; Sugawara, Shunichi; Voong, David; Wu, Fan; Yi, Jing; Deng, Yu; McCleland, Mark; Be... Journal: Lancet Issue: Volume 398:Issue 10308(2021) Page Start: 1344 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adjuvant atezolizumab in Japanese patients with resected stage IB‐IIIA non‐small cell lung cancer (IMpower010). Issue 12 (21st September 2022) Authors: Kenmotsu, Hirotsugu; Sugawara, Shunichi; Watanabe, Yasutaka; Saito, Haruhiro; Okada, Morihito; Chen‐Yoshikawa, Toyofumi Fengshi; Ohe, Yuichiro; Nishio, Wataru; Nakagawa, Shizuka; Nagao, Haruka Journal: Cancer science Issue: Volume 113:Issue 12(2022) Page Start: 4327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. ASP8273 tolerability and antitumor activity in tyrosine kinase inhibitor‐naïve Japanese patients with EGFR mutation‐positive non‐small‐cell lung cancer. Issue 8 (29th June 2018) Authors: Azuma, Koichi; Nishio, Makoto; Hayashi, Hidetoshi; Kiura, Katsuyuki; Satouchi, Miyako; Sugawara, Shunichi; Hida, Toyoaki; Iwamoto, Yasuo; Inoue, Akira; Takeda, Koji; Ikeda, Satoshi; Nakagawa, Tomoki; Takeda, Kentaro; Asahina, Seitaro; Komatsu, Kanji; Morita, Satoshi; Fukuoka, Masahiro; Nakagawa, ... Journal: Cancer science Issue: Volume 109:Issue 8(2018) Page Start: 2532 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti‐Programmed Cell Death 1 Monotherapy for Advanced Non‐Small Cell Lung Cancer. (7th November 2019) Authors: Aso, Mari; Toi, Yukihiro; Sugisaka, Jun; Aiba, Tomoiki; Kawana, Sachiko; Saito, Ryohei; Ogasawara, Takahiro; Tsurumi, Kyoji; Ono, Kana; Shimizu, Hisashi; Domeki, Yutaka; Terayama, Keisuke; Kawashima, Yosuke; Nakamura, Atsushi; Yamanda, Shinsuke; Kimura, Yuichiro; Honda, Yoshihiro; Sugawara, Shunichi Journal: Oncologist Issue: Volume 25:Number 3(2020) Page Start: e536 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Association of Immune‐Related Adverse Events with Clinical Benefit in Patients with Advanced Non‐Small‐Cell Lung Cancer Treated with Nivolumab. (22nd June 2018) Authors: Toi, Yukihiro; Sugawara, Shunichi; Kawashima, Yosuke; Aiba, Tomoiki; Kawana, Sachiko; Saito, Ryohei; Tsurumi, Kyoji; Suzuki, Kana; Shimizu, Hisashi; Sugisaka, Jun; Ono, Hirotaka; Domeki, Yutaka; Terayama, Keisuke; Nakamura, Atsushi; Yamanda, Shinsuke; Kimura, Yuichiro; Honda, Yoshihiro Journal: Oncologist Issue: Volume 23:Number 11(2018) Page Start: 1358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Association of immune‐related pneumonitis with clinical benefit of anti‐programmed cell death‐1 monotherapy in advanced non‐small cell lung cancer. (13th June 2021) Authors: Ono, Kana; Ono, Hirotaka; Toi, Yukihiro; Sugisaka, Jun; Aso, Mari; Saito, Ryohei; Kawana, Sachiko; Aiba, Tomoiki; Odaka, Tetsuo; Matsuda, Suguru; Saito, Shin; Narumi, Akane; Ogasawara, Takahiro; Shimizu, Hisashi; Domeki, Yutaka; Terayama, Keisuke; Kawashima, Yosuke; Nakamura, Atsushi; Yamanda, Sh... Journal: Cancer medicine Issue: Volume 10:Number 14(2021) Page Start: 4796 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Bevacizumab beyond disease progression after first‐line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non–small cell lung cancer (West Japan Oncology Group 5910L): An open‐label, randomized, phase 2 trial. Issue 7 (1st February 2016) Authors: Takeda, Masayuki; Yamanaka, Takeharu; Seto, Takashi; Hayashi, Hidetoshi; Azuma, Koichi; Okada, Morihito; Sugawara, Shunichi; Daga, Haruko; Hirashima, Tomonori; Yonesaka, Kimio; Urata, Yoshiko; Murakami, Haruyasu; Saito, Haruhiro; Kubo, Akihito; Sawa, Toshiyuki; Miyahara, Eiji; Nogami, Naoyuki; Na... Journal: Cancer Issue: Volume 122:Issue 7(2016) Page Start: 1050 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial. Issue 1 (January 2022) Authors: Kawashima, Yosuke; Fukuhara, Tatsuro; Saito, Haruhiro; Furuya, Naoki; Watanabe, Kana; Sugawara, Shunichi; Iwasawa, Shunichiro; Tsunezuka, Yoshio; Yamaguchi, Ou; Okada, Morihito; Yoshimori, Kozo; Nakachi, Ichiro; Seike, Masahiro; Azuma, Koichi; Kurimoto, Futoshi; Tsubata, Yukari; Fujita, Yuka; Nag... Journal: Lancet Issue: Volume 10:Issue 1(2022) Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗